Common use of Summary Table Clause in Contracts

Summary Table. The Table set forth in § 1.2 of the Lease as heretofore amended is hereby superseded and replaced in its entirety by the following table, which shall constitute the Table under § 1.2 of the Lease for all purposes from and after the Effective Date of this Fourth Amendment: PERIODS SUITE NO. RSF USF MONTHLY BASE RENT TENANT’S SHARE BLDG TENANT’S SHARE COMPLEX BASE YEAR July 1, 2016 through June 30, 2017 400 15,378 13,372 $38,445.00 6.608% 3.311% 2016 300 6,105 5,231 $15,262.50 2.623% 1.314% 2016 July 1, 2017, through June 30, 2018 400 15,378 13,372 $39,598.35 6.608% 3.311% 2016 300 6,105 5,231 $15,720.38 2.623% 1.314% 2016 In the event of any conflict between the terms contained in the Table and the terms contained in subsequent paragraphs of this Fourth Amendment, the terms of the Table shall control, except as may be expressly varied in any subsequent paragraph of this Fourth Amendment. sunesis 4a4-042216.doc (4/22/2016) page 1 of 6 [Suites 300 & 400/395 OPB; 21,483 rsf]

Summary Table. The Table set forth in § 1.2 ¶ 3 of the Lease as heretofore amended Twelfth Amendment is hereby superseded and replaced in its entirety by the following table, which shall constitute the Table under § 1.2 of the Lease as heretofore amended for all purposes from and after the Effective Date of this Fourth Thirteenth Amendment: PERIODS SUITE NO. RSF USF MONTHLY BASE RENT TENANT’S SHARE BLDG TENANT’S SHARE COMPLEX BASE YEAR July 1, 2016 2016, through June 30, 2017 400 15,378 13,372 $38,445.00 6.608505 9,255 8,048 $ 22,582.20 3.993 % 3.311% 2016 300 6,105 5,231 $15,262.50 2.623% 1.3141.992 % 2016 July 1, 2017, through June 30, 2018 400 15,378 13,372 $39,598.35 6.608505 9,255 8,048 $ 23,485.49 3.993 % 3.3111.992 % 2016 300 6,105 5,231 $15,720.38 2.623July 1, 2018, through June 30, 2019 505 9,255 8,048 $ 24,424.91 3.993 % 1.3141.992 % 2016 July 1, 2019, through June 30, 2020 505 9,255 8,048 $ 25,401.91 3.993 % 1.992 % 2016 July 1, 2020, through June 30, 2021 505 9,255 8,048 $ 25,909.95 3.993 % 1.992 % 2▇▇▇ titan pharmaceuticals 13a2-032416.doc (3/24/2016) page 1 of 5 [Suite 505, 9,255 rsf] In the event of any conflict between the terms contained in the Table and the terms contained in subsequent paragraphs of this Fourth Thirteenth Amendment, the terms of the Table shall control, except as may be expressly varied in any subsequent paragraph of this Fourth Thirteenth Amendment. sunesis 4a4-042216.doc (4/22/2016) page 1 of 6 [Suites 300 & 400/395 OPB; 21,483 rsf].